Patients with LVRR were more likely to have a history of T2DM and have non-sustained ventricular tachycardia (NSVT) during hospitalization, and have a higher proportion to use angiotensin-converting enzyme inhibitors (ACEI) or angiotensin II receptor blocker (ARB). Here, ACE is linked to type 2 diabetes mellitus.